World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
22823
World Ranking
2476
National Ranking
1184

George R. Siber publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where George R. Siber sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 200 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

George R. Siber D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where George R. Siber sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2016 - Albert B. Sabin Gold Medal, Sabin Vaccine Institute

Overview

George R. Siber is affiliated with Johns Hopkins University in the United States. Their research primarily focuses on the field of Medicine, with a particular emphasis on Infectious Diseases. Their work also covers Epidemiology, Health, Animal Science and Zoology, and Molecular Biology.

The scientist's scholarly output extensively covers topics related to SARS-CoV-2 and COVID-19 Research, including COVID-19 Clinical Research Studies and Vaccine Coverage and Hesitancy. Additional topics addressed include Pneumonia and Respiratory Infections, Animal Virus Infections Studies, Pneumocystis jirovecii pneumonia detection and treatment, and Respiratory viral infections research.

Frequent publication venues for their work include:

  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Research Square (Research Square)
  • The Journal of Infectious Diseases
  • The Lancet

Among recent papers authored or co-authored by George R. Siber are:

  • Evidence for antibody as a protective correlate for COVID-19 vaccines, 2021, Vaccine
  • Towards a population-based threshold of protection for COVID-19 vaccines, 2021, Vaccine
  • Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial, 2022, The Lancet
  • Evidence for antibody as a protective correlate for COVID-19 vaccines, 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years, 2022, Vaccine

Frequent collaborators include:

  • Donna M. Ambrosino
  • Ralf Clemens
  • David Goldblatt
  • Branda Hu
  • Igor Smolenov

Best Publications

  • Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

    Steven Black;Henry Shinefield;Bruce Fireman;Edwin Lewis

  • Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

    Eskola J;Kilpi T;Palmu A;Jokinen J

  • Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

    William P. Hausdorff;John Bryant;Peter R. Paradiso;George R. Siber

  • Evidence for antibody as a protective correlate for COVID-19 vaccines

    Kristen A. Earle;Donna M. Ambrosino;Andrew Fiore-Gartland;David Goldblatt

  • Adjuvants for human vaccines—current status, problems and future prospects☆

    Rajesh K. Gupta;George R. Siber

  • Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.

    Simin Nikbin Meydani;M. Meydani;J. B. Blumberg;L. S. Leka

  • Recurrent Sinopulmonary Infection and Impaired Antibody Response to Bacterial Capsular Polysaccharide Antigen in Children with Selective IgG-Subclass Deficiency

    Dale T. Umetsu;Donna M. Ambrosino;Isabella Quinti;George R. Siber

  • Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

    Katherine L O'Brien;Lawrence H Moulton;Raymond Reid;Robert Weatherholtz

  • Biodegradable microspheres as controlled-release tetanus toxoid delivery systems

    María J. Alonso;Rajesh K. Gupta;Caroline Min;George R. Siber

  • Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

    Luis Jódar;Jay Butler;George Carlone;Ron Dagan

  • The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II

    William P. Hausdorff;John Bryant;Carolyn Kloek;Peter R. Paradiso

  • Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

    George R. Siber;Ih Chang;Sherryl Baker;Philip Fernsten

  • Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

    Andrés de Roux;B. Schmöele-Thoma;G. R. Siber;J. G. Hackell

  • Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

    Henry R. Shinefield;Steven Black;Paula Ray;Ih Chang

  • Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children.

    William P Hausdorff;George Siber;Peter R Paradiso

  • Determinants of Release Rate of Tetanus Vaccine from Polyester Microspheres

    Maria J. Alonso;Smadar Cohen;Tae G. Park;Rajesh K. Gupta

  • Towards a population-based threshold of protection for COVID-19 vaccines

    Unknown

  • How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem

    Marc Lipsitch;George R. Siber

  • An immunodeficiency characterized by impaired antibody responses to polysaccharides.

    Donna M. Ambrosino;George R. Siber;Barbara A. Chilmonczyk;Julia B. Jernberg

  • Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.

    D M Ambrosino;G Schiffman;E C Gotschlich;P H Schur

  • Serum Serotype-Specific Pneumococcal Anticapsular Immunoglobulin G Concentrations after Immunization with a 9-Valent Conjugate Pneumococcal Vaccine Correlate with Nasopharyngeal Acquisition of Pneumococcus

    Ron Dagan;Noga Givon-Lavi;Drora Fraser;Marc Lipsitch

  • Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

    Stephen K Obaro;M. C. Steinhoff;N. Shahid;G. Siber

Frequent Co-Authors

Katherine L. O’Brien
Katherine L. O’Brien Johns Hopkins University
Mathuram Santosham
Mathuram Santosham Johns Hopkins University
Lawrence H. Moulton
Lawrence H. Moulton Johns Hopkins University
Keith P. Klugman
Keith P. Klugman Bill & Melinda Gates Foundation
Mark C. Steinhoff
Mark C. Steinhoff Cincinnati Children's Hospital Medical Center
Steven Black
Steven Black Cincinnati Children's Hospital Medical Center
William C. Gruber
William C. Gruber Pfizer (United States)
Robert W. Finberg
Robert W. Finberg University of Massachusetts Chan Medical School
Marc Lipsitch
Marc Lipsitch Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens the door to various career opportunities, many of which can be enhanced through specialized nursing programs. For professionals aiming to advance their clinical skills, exploring acute care nurse practitioner programs is a valuable step. These programs prepare nurses for high-acuity settings, complementing knowledge gained from immunology studies.

For those looking to accelerate their nursing education, an accelerated nurse practitioner program can provide a faster pathway to advanced practice roles. These online options allow students to balance studies with other commitments while gaining expertise in immunology-related healthcare fields.

Beginning a nursing career without prior experience? Many universities offer online ABSN programs for non nurses, designed to transition individuals into nursing roles efficiently. These programs often integrate foundational science knowledge alongside clinical training, essential for immunology-focused careers.

When considering entry points, some students prefer the easiest ABSN programs to get into, which may offer more accessible admissions criteria. Selecting the right program can pave the way to rewarding positions in immunology research or clinical practice, enhancing career growth in the healthcare sector.

Best Scientists Citing George R. Siber

Trending Scientists

Recently Published Articles